Drawing for SOLVENT-FREE

USPTO serial 86953878

SOLVENT-FREE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
STRUCK, ROBERT J
Law office
TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with SOLVENT-FREE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Plant and herb extracts sold as components of medicated cosmetics; Plant extracts for medical, veterinary and pharmaceutical purposes; Plant extracts for pharmaceutical purposes; Aloe vera preparations for pharmaceutical purposes; Amino acids for medical purposes; Amino acids for veterinary purposes; Antioxidant enriched coffee for medical purposes; Balms for pharmaceutical purposes; Bath preparations for medical purposes; Biological preparations for the treatment of cancer; Calcium fortified candy for medical purposes; Candy, medicated; Cartridges sold pre-filled with gases and gas mixtures for medical use; Chemical preparations for pharmaceutical or medical purposes, namely, for Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms (including those associated with multiple sclerosis), Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements for Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms (including those associated with multiple sclerosis), Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Ethers for pharmaceutical purposes; Feeding stimulants for animals; Flower essences for medical purposes for the treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms (including those associated with multiple sclerosis), Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Glycerine for medical purposes; Greases for medical purposes; Guaiacol for pharmaceutical purposes; Gummy vitamins; Hemorrhoidal ointments; Infant formula; Malt for pharmaceutical purposes; Medical lubricant, namely, vaginal lubricants; Medical preparations for the treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms (including those associated with multiple sclerosis), Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Medicated cosmetics; Medicated creams for treating dermatological conditions; Medicated dental floss; Medicated lip balm; Medicated lotions for Skin; Medicated make-up; Medicated moisturizers; Medicated pre-moistened tissues; Medicated pre-moistened towelettes; Medicated pre-moistened wipes; Medicated sun screen; Medicated sunscreen; Medicated throat sprays; Medicated Skin moisturizers; Medicinal oils; Mint for pharmaceutical purposes; Natural sleep aid preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for treating sunburn; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for treating respiratory diseases; Preparation for the relief of pain; Preparations for the treatment of burns; Royal jelly for pharmaceutical purposes; Sedatives; Sports cream for relief of pain; Sugar for medical purposes; Therapeutic medicated bath preparations; Therapeutic pharmaceutical for the treatment of Cancer, Anorexia, AIDS, Chronic pain, Cachexia, Persistent muscle spasms (including those associated with multiple sclerosis), Seizures, Epilepsy, Severe nausea, Glaucoma, Arthritis, Migraines, Any other chronic or persistent medical symptom that substantially limits the ability of the person to conduct one or more major life activities (as defined by the Americans with Disabilities Act of 1990) or, if not alleviated, may cause serious harm to the patient's safety or physical or mental health.; Vitamin enriched chewing gum for medical purposes; Vitamin enriched sparkling water for medical purposes; Vitamin enriched water for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 3, 2017MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 3, 2017ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 8, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 8, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 5, 2016DOCKASSIGNED TO EXAMINER—
Mar 30, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 29, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance